Metopirone Capsule, Gelatin Coated
Product Images NDC 68118-455

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metopirone (NDC 68118-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Esteve Pharmaceuticals, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Metopirone 01)

Chemical structure of metyrapone, showing a pyridine ring attached to a carbonyl group and an isopropyl group connected to another ring with a nitrogen atom.*

FDA Label Image

Principal Display Panel (250 mg Bottle Carton)

The packaging label for Metopirone (Metyrapone Capsules) 250 mg gelatin-coated capsules features a blue and white design with the HRA Pharma logo. The label indicates the product is supplied in an 18-capsule count and includes storage instructions and manufacturer information for Catalent Germany Eberbach GmbH, made for HRA Pharma Rare Diseases. The label displays the NDC 76336-455-18 and notes it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.